The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated safety and efficacy data from an open-label, phase 1/2 study of frontline brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A+AVD) in pediatric patients with advanced-stage classical Hodgkin lymphoma (cHL).
 
Anna Rachel Keating Franklin
No Relationships to Disclose
 
Flavio Luisi
Speakers' Bureau - Merck Sharp & Dohme
Research Funding - Merck Sharp & Dohme (Inst)
 
Mara Pianovski
Research Funding - Millennium (Inst)
 
Marco Aurelio Salvino
Consulting or Advisory Role - Janssen Diagnostics; Kite, a Gilead Company; Novartis; Takeda
Speakers' Bureau - Janssen; Kite, a Gilead Company; Novartis; Takeda
 
Franca Fagioli
Research Funding - EUSA Pharma (Inst); Gilead Sciences (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Takeda (Inst)
 
Sidnei Epelman
No Relationships to Disclose
 
Luciana Lima
No Relationships to Disclose
 
Robin Elizabeth Norris
No Relationships to Disclose
 
Vicente Odone-Filho
No Relationships to Disclose
 
Marco Zecca
Consulting or Advisory Role - Bluebird Bio; Jazz Pharmaceuticals; Medac; Vertex
Speakers' Bureau - Chimerix
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Medac
 
Claudio Favre
No Relationships to Disclose
 
Ryoji Kobayashi
No Relationships to Disclose
 
Yuhki Koga
No Relationships to Disclose
 
Yulia Sidi
Employment - Merck; Takeda
Stock and Other Ownership Interests - Merck; Takeda
 
Xiaofei Zhou
Employment - Takeda
 
Xiang Bai
Employment - Biogen; Karyopharm Therapeutics; Takeda
Stock and Other Ownership Interests - Abbvie; BeiGene; Biogen; Infinity Pharmaceuticals; Karyopharm Therapeutics; Takeda
 
Frank Campana
Employment - Takeda
Stock and Other Ownership Interests - Takeda
 
E. Jane Leonard
Employment - Takeda
Stock and Other Ownership Interests - Pfizer; Takeda
 
Franco Locatelli
Consulting or Advisory Role - Amgen; Bellicum Pharmaceuticals; Neovii; Novartis; Sanofi
Speakers' Bureau - Amgen; Bellicum Pharmaceuticals; Bluebird Bio; Gilead Sciences; Jazz Pharmaceuticals; Medacta; Miltenyi Biotec; Neovii; SOBI; Takeda